Molecular formula: | C22H25N3O3 |
Average mass: | 379.460 |
Monoisotopic mass: | 379.189592 |
ChemSpider ID: | 5078 |
0 of 1 defined stereocentres
(±)-8-[(2,3-Dihydro-1,4-benzodioxin-2-yl)methyl]-1-phenyl-1,3,8-triaza-spiro[4,5]decan-4-one
1,3,8-Triazaspiro[4.5]decan-4-one, 8-[(2,3-dihydro-1,4-benzodioxin-2-yl)methyl]-1-phenyl-
[ACD/Index Name]1054-88-2
[RN]8-(2,3-Dihydro-1,4-benzodioxin-2-ylmethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-on
[German]
[ACD/IUPAC Name]8-(2,3-Dihydro-1,4-benzodioxin-2-ylmethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
[ACD/IUPAC Name]8-(2,3-Dihydro-1,4-benzodioxin-2-ylméthyl)-1-phényl-1,3,8-triazaspiro[4.5]décan-4-one
[French]
[ACD/IUPAC Name]DR0QR50ALL
[UNII]Espiroxatrina
[Spanish]
[INN]Spiroxatrine
[INN]Spiroxatrinum
[Latin]
1,3,8-Trianaspiro(4.5)decane-4-one,8-(1,4-benzodioxan-2-ylmethyl)-1-phenyl-
5-hydroxytryptamine receptor 1A
5-hydroxytryptamine receptor 2B
5HT1A_HUMAN
5HT1A_RAT
5HT2B_HUMAN
5HT2B_RAT
8-((2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
8-(1,4-Benzodioxan-2-ylmethyl)-1-phenyl-1,3,8-trianaspiro(4,5)decane-4-one
8-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
8-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-4-phenyl-2,4,8-triazaspiro[4.5]decan-1-one
8-(2,3-Dihydro-benzo[1,4]dioxin-2-ylmethyl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one
8-(7,10-dioxabicyclo[4.4.0]deca-1,3,5-trien-8-ylmethyl)-4-phenyl-2,4,8-triazaspiro[4.5]decan-1-one
8-[(2,3-Dihydro-1,4-benzodioxin-2-yl)methyl]-1-phenyl-1,3,8-triazaspiro[4,5]decan-4-one
ADA2A_BOVIN
ADA2A_HUMAN
ADA2A_PIG
ADA2A_RAT
ADA2B_DIDVI
ADA2B_HUMAN
ADA2B_RABIT
ADA2B_RAT
ADA2C_DIDVI
ADA2C_HUMAN
ADA2C_RAT
D(2) dopamine receptor
DRD2_RAT
espiroxatrina
G3GWB4_CRIGR
Q9MZ11_RABIT
spiroxamide
Spiroxatrine (R 5188)
spiroxatrinum
α-2A adrenergic receptor
α-2A adrenergic receptor [16-465]
α-2B adrenergic receptor
α-2C adrenergic receptor
спироксатрин
[Russian]سبيروكساترين
[Arabic]螺沙群
[Chinese]